N
Nunzia Garbino
Researcher at Synlab Group
Publications - 12
Citations - 92
Nunzia Garbino is an academic researcher from Synlab Group. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 2, co-authored 9 publications receiving 20 citations.
Papers
More filters
Journal ArticleDOI
Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
Valeria Romeo,Giuseppe Accardo,Teresa Perillo,Luca Basso,Nunzia Garbino,Emanuele Nicolai,Simone Maurea,Marco Salvatore +7 more
TL;DR: In this article, the authors compared the accuracy of conventional and advanced imaging techniques as well as discuss the application of artificial intelligence tools in the assessment of tumor response after NAC and described the role of advanced imaging technique such as MRI, nuclear medicine, and new hybrid PET/MRI imaging in the prediction of the response to NAC.
Journal ArticleDOI
Hybrid 18F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study
Concetta Schiano,Monica Franzese,Katia Pane,Nunzia Garbino,Andrea Soricelli,Marco Salvatore,Filomena de Nigris,Claudio Napoli +7 more
TL;DR: The combination of functional 18F-FDG-PET/MRI parameters and molecular determination of YY1 could represent a novel integrated approach to predict synchronous metastatic disease with more accuracy than18F- FDG- PET/MRI alone.
Journal ArticleDOI
Brown Adipose Tissue in Breast Cancer Evaluated by [18F] FDG-PET/CT.
TL;DR: A relation between BAT activation and positive known prognostic factor in breast cancer, such as intermediate tumor grade and luminal B cancer type, is suggested.
Journal ArticleDOI
MRI-Based Radiomic Features Help Identify Lesions and Predict Histopathological Grade of Hepatocellular Carcinoma
TL;DR: Radiomics MRI based on T2 and DCE-MRI revealed promising results concerning both HCC detection and grading, and may be a suitable tool for personalized treatment of HCC patients and could also be used to develop new prognostic biomarkers useful for HCC assessment without the need for invasive procedures.
Journal ArticleDOI
A Complex Radiomic Signature in Luminal Breast Cancer from a Weighted Statistical Framework: A Pilot Study
Rossana Castaldo,Nunzia Garbino,Carlo Cavaliere,Mariarosaria Incoronato,Luca Basso,Renato Cuocolo,Leonardo Pace,Marco Salvatore,Monica Franzese,Emanuele Nicolai +9 more
TL;DR: This pilot study helped to establish a robust framework of analysis to generate a combined radiomic signature, which may lead to more precise breast cancer prognosis, as well as to explore radiomic biomarkers for a better characterization of the radiogenomic phenotypes in breast cancer.